press

CorTec has announced today that the US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application by the University of Washington School of Medicine (UW) involving the closed-loop Brain Interchange Implant System. This clinical study will investigate a novel stroke rehabilitation treatment using cortical stimulation to enhance plasticity within the brain. …

FDA approves Investigational Device Exemption for Early Feasibility Study for rehabilitation of stroke patients using CorTec’s Closed-Loop Brain Interchange implant system. Read More »

German medical technology innovator poised to make waves after implantation of a brain chip by Neuralink in a human trial As it prepares for the next stage of its groundbreaking device for the treatment of stroke, CorTec GmbH, a pioneering German medical technology company, is poised to make significant strides in the field of neurotechnology. …

Press Release: CorTec ready for next phase with Brain Interchange System Read More »

Dr. Oliver Bärtl joins CorTec’s executive leadership team. Prof. Dr. Tim Denison, Prof. Dr. Pascal Fries, Dr. Christoph Mangold and Helmut Jeggle become new members of CorTec’s Advisory Board. CorTec GmbH, a Medical Device innovation leader located in Freiburg, Germany, announced that Dr. Oliver Bärtl has been appointed Chief Executive Officer. He complements the existing …

CorTec strengthens Executive Leadership Team and Advisory Board Read More »

Prof. Kerstin Krieglstein, Rector of the University of Freiburg, presents the first edition of the newly established Bernstein-CorTec Prize for Computational Neuroscience and Neurotechnology to two young researchers, Júlia Gallinaro and Katharina Heining, in the afternoon of November 4, for Corona-reasons in virtual format. Both awardees will present their research in an Extra Bernstein Seminar …

Two first prize winners of the Bernstein-CorTec Award Read More »

Dr. Harald Poth, Marco Winzer and Prof. Dr. Pascal Fries new members of CorTecs Advisory Board Following the conclusion of a new round of investments last fall, CorTec is now expanding the expertise in the two advisory boards of the medical technology company. Dr. Harald Poth from LBBW Venture Capital GmbH joins the company’s Advisory …

With refreshed support into the future of neurotechnology Read More »

Today CorTec announced the close of a €13 million funding. The investor consortium is led by Santo Venture Capital, the Strüngmann family holding company. Alongside LBBW Venture Capital, several existing shareholders participate in the funding round. Based on the investments, CorTec plans the next step of expansion with a subsidiary in the USA and the …

Strüngmann Group invests in further expansion of CorTec Read More »

CorTec and the Wyss Center, a non-profit neurotechnology translation organization, have signed a partnership agreement. They will collaborate in developing a novel, minimally invasive brain monitoring and stimulation device. The partners will work together on research, design and development of a device for continuous, long-term, monitoring of the brain’s electrophysiological signals for clinical diagnostic and …

Wyss Center announces collaboration with CorTec Read More »

For the first time an intervention based on tailor-made electrodes from CorTec was performed at the University Hospital of Goethe University in Frankfurt: The seven-year-old girl with epilepsy is seizure-free since the surgery. Epilepsy is an extremely devastating disease, in particular in children like seven-year-old Nora. Until now her day was dominated by up to …

Little Girl Overcomes Big Disease – Thanks to Latest Technology Read More »